Experimental studies show that sleep enhances the clearance of Aβ, tau, and related metabolites, whereas sleep disruption, aging, vascular dysfunction, and AQP4 abnormalities impair this process and may accelerate AD-related pathology. Here, AQP4 is linked to Alzheimer disease.